681TopLevel: Yes

Axplora expands in India

13th August 2025

Submitted by:

Andrew Warmington

Axplora has announced a “significant” investment at its site in Vizag, India (pictured)

Esteve acquires Regis

4th August 2025

Submitted by:

Andrew Warmington

 

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago, and

Ofichem buys site in Sweden

4th August 2025

Submitted by:

Andrew Warmington

Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which

Nucleic acid API boost

30th June 2025

Submitted by:

Andrew Warmington

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Flamma opens in China

30th June 2025

Submitted by:

Andrew Warmington

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

CDMOs in ADC investments

10th June 2025

Submitted by:

Andrew Warmington

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Halozyme abandons Evotec bid

28th November 2024

Submitted by:

Andrew Warmington

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Subscribe to Pharmaceuticals